These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children. Yiu EM; Laughlin S; Verhey LH; Banwell BL; J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896 [TBL] [Abstract][Full Text] [Related]
14. Neutropenia as a Complication of Tumefactive Demyelinating Disease: A Case Report. Webb K; Osorio M PM R; 2018 Aug; 10(8):877-879. PubMed ID: 29330070 [TBL] [Abstract][Full Text] [Related]
16. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Mao-Draayer Y; Braff S; Pendlebury W; Panitch H Neurology; 2002 Oct; 59(7):1074-7. PubMed ID: 12370466 [TBL] [Abstract][Full Text] [Related]
17. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391 [TBL] [Abstract][Full Text] [Related]
18. Tumefactive demyelination versus tumor; A diagnostic dilemma: Role of electron microscopy. Doshi P; Ramdasi R; Thorve S; Khubchandani S Indian J Pathol Microbiol; 2018; 61(4):638-640. PubMed ID: 30303176 [No Abstract] [Full Text] [Related]